It aims to develop an innovative biotechnological therapy based on enzybiotics to tackle hospital-acquired infections, particularly those caused by multidrug-resistant bacteria such as Acinetobacter baumannii.

It aims to develop an innovative multisensory medical device for the detection and personalised treatment of hemispatial neglect and other brain impairments in patients who have suffered a stroke.

It aims to expand the roadmap for functional and additive printing focused on the health sector, accessibility and wellbeing, in order to improve the competitiveness of our value-chain partners by identifying the key capabilities to be developed in the short to medium term.